Skip to content
Sign in

CCEL · AMEX

Cryo-Cell International (CCEL) Stock Price & Fundamentals

$386.09+0.28%+$1.08End-of-day price as of Oct 9, 2026

Cryo-Cell International (CCEL) closed at $386.09 on Oct 9, 2026, up 0.28% from the previous close of $385.01.

Share price, past year

1Y +26.06%

52-week range $297.13 – $405.08. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$386.09
Sep 30, 2026$384.02
Aug 31, 2026$397.72
Jul 31, 2026$384.74
Jun 30, 2026$376.97
May 29, 2026$377.54
Apr 30, 2026$354.02
Mar 31, 2026$339.75
Feb 27, 2026$342.75
Jan 30, 2026$318.94
Dec 31, 2025$318.83
Nov 28, 2025$304.15
Oct 31, 2025$309.93

Key statistics

Market cap
$3.11B
P/E (TTM)
1,838.5
EPS (TTM)
$0.21
Revenue (TTM)
$31.13M
Net income (TTM)
−$2.47M
Shares outstanding
8.1M
Dividend yield
—
52-week range
$297.13 – $405.08

Cryo-Cell International's market cap is $3.11B, based on a share price of $386.09 and 8.1M shares outstanding as of May 31, 2026.

Financials

Cryo-Cell International reported revenue of $31.57M for fiscal 2025, down 1.31% from fiscal 2024.

Cryo-Cell International reported a net loss of $2.43M in fiscal 2025.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Cryo-Cell International annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Nov 30, 2025$31.57M−1.3%−$2.43M−7.7%−$0.30$5.25M
FY2024ended Nov 30, 2024$31.99M+2.1%$402.10K1.3%$0.05$3.61M
FY2023ended Nov 30, 2023$31.34M+3.3%−$9.52M−30.4%−$1.14$2.08M
FY2022ended Nov 30, 2022$30.34M+5.0%$2.77M9.1%$0.33−$3.60M
FY2021ended Nov 30, 2021$28.88M−7.3%$2.08M7.2%$0.25$6.09M
FY2020ended Nov 30, 2020$31.15M−2.1%$3.62M11.6%$0.45$8.37M
FY2019ended Nov 30, 2019$31.82M+8.9%$2.29M7.2%$0.27$5.63M
FY2018ended Nov 30, 2018$29.22M+15.1%−$854.82K−2.9%−$0.11$4.89M
FY2017ended Nov 30, 2017$25.38M+9.8%$2.32M9.1%$0.30$5.62M
FY2016ended Nov 30, 2016$23.13M—−$1.32M−5.7%−$0.16—
Cryo-Cell International quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended May 31, 2026$7.78M$554.59K$0.07
Q1 FY2026ended Feb 28, 2026$7.68M$47.11K$0.01
Q4 FY2025ended Nov 30, 2025$7.84M−$3.82M—
Q3 FY2025ended Aug 31, 2025$7.83M$749.41K$0.09
Q2 FY2025ended May 31, 2025$7.93M$355.79K$0.04
Q1 FY2025ended Feb 28, 2025$7.97M$282.86K$0.03
Q4 FY2024ended Nov 30, 2024$8.02M−$1.86M—
Q3 FY2024ended Aug 31, 2024$8.07M$1.05M$0.13

Company profile

Name
Cryo-Cell International, Inc.
Ticker
CCEL
Exchange
AMEX
Industry (SEC SIC)
Services-Misc Health & Allied Services, NEC
Headquarters
700 Brooker Creek Blvd, Suite 1800, Oldsmar, FL 34677
Incorporated in
DE
Fiscal year ends
November
SEC CIK
0000862692

Recent SEC filings

Frequently asked questions

What is Cryo-Cell International's stock price?

Cryo-Cell International (CCEL) closed at $386.09 on Oct 9, 2026, up 0.28% from the previous close of $385.01.

What is Cryo-Cell International's market cap?

Cryo-Cell International's market cap is $3.11B, based on a share price of $386.09 and 8.1M shares outstanding as of May 31, 2026.

How much revenue does Cryo-Cell International make?

Cryo-Cell International reported revenue of $31.57M for fiscal 2025, down 1.31% from fiscal 2024.

What is CCEL's P/E ratio?

Cryo-Cell International's price-to-earnings ratio is 1,838.5, based on trailing twelve-month diluted EPS of $0.21.

Does Cryo-Cell International pay a dividend?

Cryo-Cell International's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Cryo-Cell International, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures